AI Science Tracker
EN

Development and validation of a multiphase CT radiomics-based machine learning model for prognostic prediction in sarcomatoid renal cell carcinoma.

Affiliation not stated in the reviewed material · 30 Oct 2026 · medicine

Discovery

Development and validation of a multiphase CT radiomics-based machine learning model for prognostic prediction in sarcomatoid renal cell carcinoma.

Source check: Source checked. Not independent scientific confirmation.

Finding: The combined model reached test C-index 0.737; difference from clinical model was not significant (P=0.115). CT radiomics combined with clinical predictors in a multiphase model for sarcomatoid renal-cell carcinoma. Testing: Held-out internal test and bootstrap/cross-validation are reported; small cohort and nonsignificant gain constrain claim.. Source affiliation was not stated in the reviewed case checks and was unavailable in the local bibliographic cache.

Technology: CT radiomics combined with clinical predictors in a multiphase model for sarcomatoid renal-cell carcinoma.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
CT radiomics combined with clinical predictors in a multiphase model for sarcomatoid renal-cell carcinoma.
Test and result
Held-out internal test and bootstrap/cross-validation are reported; small cohort and nonsignificant gain constrain claim.
Limitation / still unknown
The combined model reached test C-index 0.737; difference from clinical model was not significant (P=0.115).
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fonc.2026.1982796

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.